• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Clinical Data

image-icon
Clinical trial failure flop
Special Reports

2021's top 10 clinical trial flops

Thousands of studies are registered each year, so there is always an array of disappointing results to choose from for our annual top 10 list.
Phil Taylor Mar 1, 2022 3:00am
ovarian cancer cancer awareness

Agenus gets boost for combo drug, this time in ovarian cancer

Mar 27, 2023 9:45am
AZ

66-week data put AstraZeneca on route to rare disease approval

Mar 27, 2023 4:44am
image of a generic nasal spray

VistaGen's social anxiety nasal spray finds open-label success

Mar 22, 2023 3:36pm
Liver disease

89bio hits primary goals in midphase NASH trial, plots phase 3

Mar 22, 2023 8:31am
Astellas

Astellas' drug against hot cancer target hits again in phase 3

Mar 22, 2023 6:30am
More News

Selecta, Sobi rout gout in phase 3 trials to take on Horizon

Mar 21, 2023 7:40am

Hype builds for Karuna's schizophrenia drug with phase 3 data

Mar 20, 2023 12:03pm

Takeda's $4B drug clears psoriasis in one-third of patients

Mar 20, 2023 8:15am

Cash-strapped Acer sees menopause drug flunk phase 2 trial

Mar 17, 2023 10:11am
See more stories
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy